Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

Apex Consumer Court slaps Rs 35 lakh compensation on Johnson & Johnson for faulty hip replacement device

Ruchika Sharma1 Oct 2024 12:35 PM IST

New Delhi: In a significant ruling, the National Consumer Disputes Redressal Commission (NCDRC) has ordered Johnson & Johnson Limited to...

Zydus Bags USFDA Nod for Eltrombopag Tablets Across Four Strengths

Zydus, CSIR-CDRI Lucknow to develop drug for Chronic Kidney Disease induced Osteoporosis

Ruchika Sharma1 Oct 2024 11:30 AM IST

Ahmedabad: Zydus Lifesciences Ltd, Ahmedabad has signed a collaborative research agreement with Central Drug Research Institute, Lucknow for the...

Biocon Gets USFDA Approval for Everolimus Oral Suspension in Pediatric, Adult TSC

Biocon gets 4 USFDA observations for Bengaluru facility

Ruchika Sharma30 Sept 2024 6:45 PM IST

Bangalore: Biocon has announced that the U.S Food and Drug Administration (US FDA) has concluded a surveillance inspection with four...

Aurobindo Pharma China Plant incurring loss, break even expected by Q4

Aurobindo Pharma arm Telangana facility gets 10 USFDA observations

Ruchika Sharma30 Sept 2024 5:01 PM IST

Telangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has issued ten observations at the closure...

USFDA concludes inspection at Biocon Biologics Malaysia Insulins facility

Ruchika Sharma30 Sept 2024 1:15 PM IST

Karnataka: Biocon Biologics has announced that the US Food and Drug Administration (USFDA) has completed a cGMP inspection at the Company's...

Strides Pharma Science arm New York facility gets 4 USFDA observations

USFDA issues EIR for Piramal Pharma Ahmedabad facility

Ruchika Sharma30 Sept 2024 12:11 PM IST

Mumbai: Piramal Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its...

Zydus Lifesciences gets USFDA nod for prostate cancer drug Enzalutamide

Ruchika Sharma30 Sept 2024 11:15 AM IST

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture...

AbbVie gets USFDA nod for Epkinly, Rituximab, Lenalidomide combo for Follicular Lymphoma

AbbVie seeks USFDA accelerated approval for telisotuzumab vedotin for previously treated non small cell lung cancer

Ruchika Sharma29 Sept 2024 1:15 PM IST

North Chicago: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...

Bad Times for Sanofi Healthcare? Market Signals Suggest Growing Pressure

Sanofi, Regeneron get USFDA nod for Dupixent for COPD

Ruchika Sharma29 Sept 2024 12:30 PM IST

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment...

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

USFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults

Ruchika Sharma29 Sept 2024 10:00 AM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY (xanomeline and trospium...

Lupin rolls out constipation drug Prucalopride in US after USFDA nod

Upcoming 50 pharma manufacturing plants under PLI scheme to be completed in 2 years: Centre

Ruchika Sharma28 Sept 2024 4:52 PM IST

New Delhi: The Centre has informed that the 50 upcoming pharmaceutical manufacturing plants under the production-linked incentive (PLI) scheme...

Alembic Pharma secures USFDA approval for Travoprost Ophthalmic Solution

Alembic Pharma receives USFDA EIR for Oral solid formulation facility (F-1) at Panelav

Ruchika Sharma28 Sept 2024 4:37 PM IST

Vadodara: Alembic Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok